
New Buy Rating for DSM-Firmenich AG (DSFIR), the Basic Materials Giant
Deutsche Bank analyst Virginie Boucher-Ferte maintained a Buy rating on DSM-Firmenich AG (DSFIR – Research Report) yesterday and set a price target of €132.00. The company's shares closed yesterday at €93.44.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Boucher-Ferte is a 4-star analyst with an average return of 4.1% and a 58.96% success rate. Boucher-Ferte covers the Basic Materials sector, focusing on stocks such as BASF SE, Arkema, and DSM-Firmenich AG.
DSM-Firmenich AG has an analyst consensus of Strong Buy, with a price target consensus of €127.13, representing a 36.06% upside. In a report released on June 23, Barclays also maintained a Buy rating on the stock with a €128.00 price target.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
41 minutes ago
- Business Insider
UBS Sticks to Their Buy Rating for Mahanagar Gas Ltd (MGL)
In a report released on June 27, Rwibhu Aon from UBS maintained a Buy rating on Mahanagar Gas Ltd (MGL – Research Report), with a price target of INR1,650.00. The company's shares closed last Friday at INR1,511.80. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Aon is a 2-star analyst with an average return of 7.9% and a 100.00% success rate. Currently, the analyst consensus on Mahanagar Gas Ltd is a Moderate Buy with an average price target of INR1,559.67, a 3.17% upside from current levels. In a report released on June 17, Nomura also upgraded the stock to a Buy with a INR1,680.00 price target. Based on Mahanagar Gas Ltd's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of INR19.64 billion and a net profit of INR2.47 billion. In comparison, last year the company earned a revenue of INR16.13 billion and had a net profit of INR2.52 billion


Business Insider
an hour ago
- Business Insider
William Blair Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)
William Blair analyst Matt Phipps reiterated a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday. The company's shares closed last Friday at $441.30. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Phipps covers the Healthcare sector, focusing on stocks such as Cullinan Management, Genmab, and Bristol-Myers Squibb. According to TipRanks, Phipps has an average return of -9.1% and a 36.43% success rate on recommended stocks. In addition to William Blair, Vertex Pharmaceuticals also received a Buy from H.C. Wainwright's Andrew Fein in a report issued on June 23. However, on June 27, RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (NASDAQ: VRTX).


Business Insider
8 hours ago
- Business Insider
Gaztransport et technigaz (0QT5) Gets a Buy from Kepler Capital
In a report released on June 27, Kevin Roger from Kepler Capital maintained a Buy rating on Gaztransport et technigaz (0QT5 – Research Report), with a price target of €210.00. The company's shares closed last Friday at €167.10. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Roger is a 5-star analyst with an average return of 14.6% and a 65.33% success rate. Roger covers the Energy sector, focusing on stocks such as Saipem SpA, Subsea 7, and Gaztransport et technigaz. Currently, the analyst consensus on Gaztransport et technigaz is a Moderate Buy with an average price target of €177.25. Based on Gaztransport et technigaz's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €346.61 million and a net profit of €177.45 million. In comparison, last year the company earned a revenue of €249.9 million and had a net profit of €117.34 million